Ellevest’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Buy
1,230
+217
+21% +$50.5K 0.03% 365
2026
Q2
$237K Buy
1,013
+4
+0.4% +$831 0.03% 416
2026
Q1
$213K Sell
1,009
-10
-1% -$2.15K 0.03% 408
2025
Q4
$209K Buy
+1,019
New +$192K 0.03% 402
2023
Q2
– Sell
-39
Closed -$2.94K – 560
2023
Q1
$2.94K Buy
39
+24
+160% +$1.81K ﹤0.01% 1359
2022
Q4
$1.15K Buy
+15
New +$1.14K ﹤0.01% 1491
2021
Q2
– Sell
-8
Closed – – 1277
2021
Q1
$0 Sell
8
-375
-98% -$20.7K ﹤0.01% 1264
2020
Q4
$21K Buy
383
+114
+42% +$5.92K ﹤0.01% 618
2020
Q3
$13K Buy
269
+5
+2% +$257 ﹤0.01% 601
2020
Q2
$14K Buy
264
+44
+20% +$2.27K ﹤0.01% 541
2020
Q1
$11K Buy
220
+13
+6% +$675 ﹤0.01% 537
2019
Q4
$10K Buy
+207
New +$10.7K ﹤0.01% 526

Other funds holding CAH

Ellevest's CAH Position: Q3 2026 in Review

Ellevest increased its Cardinal Health (CAH) stake by 21% in Q3 2026, buying an estimated $50.5K and bringing the position to 1,230 shares worth $270K. The position accounts for 0.03% of the portfolio, ranked #365.

Ellevest first reported a position in CAH in Q4 2019 and has held it in 12 quarters since. 1,272 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Ellevest held 1,230 shares of Cardinal Health worth $270K as of Q3 2026.
  • Ellevest bought 217 Cardinal Health shares in Q3 2026, an estimated $50.5K.
  • Cardinal Health made up 0.03% of Ellevest's portfolio in Q3 2026, its #365 holding.
  • Ellevest first reported a position in Cardinal Health in Q4 2019 and has held it in 12 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.